[Aggravation of @entity302 by @entity1092 in a @entity1 with cryptogenic localization-related XXXX ].

@entity1 @entity410 @entity38761 @entity198 @entity2050 @entity1092 @entity1445 @entity2052 @entity302 @entity2049
We report a paradoxical effect of @entity1092 ( @entity2052 ) observed in a 3-year-old @entity1 with cryptogenic localization-related @entity302 . On admission she experienced two types of @entity410 that were confirmed by ictal EEGs : @entity410 ( @entity410 ) originating from the left hemisphere and combined @entity410 that began with repetitive @entity410 immediately followed by a @entity38761 . These @entity410 did not possess asymmetrical features, but the ictal EEGs showed left-side dominant multiple spike-waves. The patent's interictal EEGs on admission showed left posterior temporal- parietal spikes during wakefulness and frequent diffuse spike-waves during sleep. In the process of introduction and increase in the dosage of @entity2052 , an aggravation of @entity302 discharges, especially a dramatic increase in diffuse spike-waves during sleep, was observed. In the same period of time, @entity410 not followed by @entity38761 newly appeared, and there was an increase in the frequency of @entity410 and combined @entity410 . Marked improvement of @entity302 discharges, namely the disappearance of diffuse discharges, and complete suppression of all types of @entity410 were achieved by the introduction of @entity2049 ( @entity2050 ) along with the withdrawal of @entity2052 . During the clinical course, the @entity1 did not display any signs or symptoms of @entity2052 @entity198 , @entity1445 of @entity2052 or metabolic aberration. The paradoxical effect of @entity2050 in localization-related @entity302 is well-known, yet in this case, @entity2052 displayed a similar paradoxical effect. Additionally, @entity2050 was efficacious in the suppression of secondary bilateral synchrony on EEG and also successfully controlled @entity410 , combined @entity410 and @entity410 .
